These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 25320002)

  • 21. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost of dementia in the pre-enlargement countries of the European Union.
    Luengo-Fernandez R; Leal J; Gray AM
    J Alzheimers Dis; 2011; 27(1):187-96. PubMed ID: 21860095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare resource utilization and cost in dementia: are there differences between patients screened positive for dementia with and those without a formal diagnosis of dementia in primary care in Germany?
    Michalowsky B; Eichler T; Thyrian JR; Hertel J; Wucherer D; Hoffmann W; Flessa S
    Int Psychogeriatr; 2016 Mar; 28(3):359-69. PubMed ID: 26446797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic costs of dementia in Korea, 2002.
    Suh GH; Knapp M; Kang CJ
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):722-8. PubMed ID: 16858741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic Analysis of Formal Care, Informal Care, and Productivity Losses in Primary Care Patients who Screened Positive for Dementia in Germany.
    Michalowsky B; Thyrian JR; Eichler T; Hertel J; Wucherer D; Flessa S; Hoffmann W
    J Alzheimers Dis; 2016; 50(1):47-59. PubMed ID: 26639964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The societal costs of dementia in Sweden 2012 - relevance and methodological challenges in valuing informal care.
    Wimo A; Jönsson L; Fratiglioni L; Sandman PO; Gustavsson A; Sköldunger A; Johansson L
    Alzheimers Res Ther; 2016 Nov; 8(1):59. PubMed ID: 27986093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of costs of care for patients with Alzheimer's disease.
    Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
    Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic cost of dementia patients according to the limitation of the activities of daily living in Korea.
    Kang IO; Lee SY; Kim SY; Park CY
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):675-81. PubMed ID: 17171741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.
    Kenne Malaha A; Thébaut C; Achille D; Preux PM; Guerchet M
    J Alzheimers Dis; 2023; 91(1):115-128. PubMed ID: 36404540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monetary costs of Alzheimer's disease in China: protocol for a cluster-randomised observational study.
    Li F; Chen S; Wei C; Jia J
    BMC Neurol; 2017 Jan; 17(1):15. PubMed ID: 28122529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The economic impact of dementia in Belgium: results of the National Dementia Economic Study (NADES).
    Scuvee-Moreau J; Kurz X; Dresse A;
    Acta Neurol Belg; 2002 Sep; 102(3):104-13. PubMed ID: 12400248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost measurement of mental disorders in Germany.
    Grupp H; Köenig HH; Konnopka A
    J Ment Health Policy Econ; 2014 Mar; 17(1):3-8. PubMed ID: 24864116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost-of-illness study of asthma in Korea: estimated from the Korea National Health insurance claims database].
    Park CS; Kang HY; Kwon I; Kang DR; Jung HY
    J Prev Med Public Health; 2006 Sep; 39(5):397-403. PubMed ID: 17076180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economic burden of dementia in China, 1990-2030: implications for health policy.
    Xu J; Wang J; Wimo A; Fratiglioni L; Qiu C
    Bull World Health Organ; 2017 Jan; 95(1):18-26. PubMed ID: 28053361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Costs of care for dementia patients in community setting: an analysis for mild and moderate disease stage.
    Schwarzkopf L; Menn P; Kunz S; Holle R; Lauterberg J; Marx P; Mehlig H; Wunder S; Leidl R; Donath C; Graessel E
    Value Health; 2011; 14(6):827-35. PubMed ID: 21914502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An estimate of the worldwide prevalence and direct costs of dementia in 2003.
    Wimo A; Jonsson L; Winblad B
    Dement Geriatr Cogn Disord; 2006; 21(3):175-81. PubMed ID: 16401889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The worldwide societal costs of dementia: Estimates for 2009.
    Wimo A; Winblad B; Jönsson L
    Alzheimers Dement; 2010 Mar; 6(2):98-103. PubMed ID: 20298969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive cost of illness of dementia in Japan: a time trend analysis based on Japanese official statistics.
    Hanaoka S; Matsumoto K; Kitazawa T; Fujita S; Seto K; Hasegawa T
    Int J Qual Health Care; 2019 Apr; 31(3):231-237. PubMed ID: 30272131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-of-illness studies : a review of current methods.
    Akobundu E; Ju J; Blatt L; Mullins CD
    Pharmacoeconomics; 2006; 24(9):869-90. PubMed ID: 16942122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.